SCHEMBL16014093

SCHEMBL16014093

Cc1ccccc1NNC(=O)C(=O)NC(Cc1ccc(-c2cccc(Cl)c2)cc1)CC(O)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.69
▸ ACE P12821 11/20 0.69
▸ MMEL1 Q495T6 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16008020 1.00 MME (0.69) MMEACEMMEL1
SCHEMBL16021285 0.91 MME (0.67) MMEACEMMEL1
SCHEMBL16008337 0.91 MME (0.71) MMEACE
SCHEMBL16009036 0.89 MME (0.69) MMEACE
SCHEMBL16008712 0.88 MME (0.76) MMEACEMMEL1
SCHEMBL18386354 0.87 MME (0.61) MMEACEMMEL1
SCHEMBL16008048 0.86 MME (0.70) MMEACEMMEL1
SCHEMBL16008018 0.86 MME (0.76) MMEACEMMEL1
SCHEMBL16008705 0.86 MME (0.78) MMEACEMMEL1
SCHEMBL16008585 0.85 MME (0.69) MMEACEMMEL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964616-A1 NEPRILYSIN INHIBITORS Theravance Biopharma R&D IP, LLC (US) 2016-01-13 — — EP disclosed
WO-2014138053-A1 NEPRILYSIN INHIBITORS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2014-09-12 — — WO disclosed
Send feedback